TW325469B - 5,6-Dihydro-dibenz[b,e]azepine-6,11-dione-11-oximes - Google Patents

5,6-Dihydro-dibenz[b,e]azepine-6,11-dione-11-oximes

Info

Publication number
TW325469B
TW325469B TW081108553A TW81108553A TW325469B TW 325469 B TW325469 B TW 325469B TW 081108553 A TW081108553 A TW 081108553A TW 81108553 A TW81108553 A TW 81108553A TW 325469 B TW325469 B TW 325469B
Authority
TW
Taiwan
Prior art keywords
chain
carbon atoms
branched
straight
halogen
Prior art date
Application number
TW081108553A
Other languages
English (en)
Chinese (zh)
Inventor
Wild Hanno
Roeben Wolfgang
Aichinger Gerd
Paessens Arnold
Petersen-Von Gehr Jorg
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of TW325469B publication Critical patent/TW325469B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/20—Dibenz [b, e] azepines; Hydrogenated dibenz [b, e] azepines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
TW081108553A 1991-11-27 1992-10-28 5,6-Dihydro-dibenz[b,e]azepine-6,11-dione-11-oximes TW325469B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4138853A DE4138853A1 (de) 1991-11-27 1991-11-27 5,6-dihydro-dibenz(b,e)azepin-6,11-dion-11- oxime

Publications (1)

Publication Number Publication Date
TW325469B true TW325469B (en) 1998-01-21

Family

ID=6445615

Family Applications (1)

Application Number Title Priority Date Filing Date
TW081108553A TW325469B (en) 1991-11-27 1992-10-28 5,6-Dihydro-dibenz[b,e]azepine-6,11-dione-11-oximes

Country Status (16)

Country Link
US (1) US5416209A (fr)
EP (1) EP0544171B1 (fr)
JP (1) JPH05246996A (fr)
KR (1) KR100234924B1 (fr)
AT (1) ATE114115T1 (fr)
AU (1) AU650800B2 (fr)
CA (1) CA2083798A1 (fr)
DE (2) DE4138853A1 (fr)
DK (1) DK0544171T3 (fr)
ES (1) ES2063562T3 (fr)
GR (1) GR3014990T3 (fr)
HU (2) HUT65451A (fr)
IL (1) IL103855A (fr)
NZ (1) NZ245263A (fr)
TW (1) TW325469B (fr)
ZA (1) ZA929175B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8524157D0 (en) * 1984-10-19 1985-11-06 Ici America Inc Heterocyclic amides
DE4138908A1 (de) * 1991-11-27 1993-06-03 Bayer Ag 6-thiono-dibenz(b,e)azepine
CN102153513B (zh) * 2011-02-28 2012-05-30 中国农业大学 烃氧亚氨基二苯并己内酰胺衍生物及其制备方法与作为杀菌剂的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1545856A1 (de) * 1965-09-10 1969-11-27 Bayer Ag Verfahren zur Herstellung von basisch substituierten Derivaten des 5,6-Dihydro-dibenz-[b,e]-azepin-6,11-dion-11-oxims
GB1132516A (en) * 1966-02-01 1968-11-06 Ici Ltd Morphanthridine derivatives
IT1207417B (it) * 1982-03-15 1989-05-17 Menarini Sas Azepina-6-one ad attivita'composti triciclici derivati dalla farmacologica, e procedimenti di 5,6-diidro-11h-dibenzo (b,e)fabbricazione relativi
ATE129637T1 (de) * 1989-08-29 1995-11-15 Boehringer Ingelheim Pharma Verwendung von dibenzo(b,f>(1,4>oxazepin (und thiazepin)-11(10h)-one und -thione zur herstellung eines arzneimittels zur prävention und behandlung von aids.
CA2030056C (fr) * 1989-11-17 1995-10-17 Karl D. Hargrave 5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepines et leur utilisation pour la prevention ou le traitement de l'infection par le hiv

Also Published As

Publication number Publication date
IL103855A0 (en) 1993-04-04
CA2083798A1 (fr) 1993-05-28
DE4138853A1 (de) 1993-06-03
IL103855A (en) 1996-09-12
DK0544171T3 (da) 1995-05-01
HUT65451A (en) 1994-06-28
KR930010002A (ko) 1993-06-21
EP0544171A1 (fr) 1993-06-02
US5416209A (en) 1995-05-16
ES2063562T3 (es) 1995-01-01
NZ245263A (en) 1997-05-26
KR100234924B1 (ko) 1999-12-15
EP0544171B1 (fr) 1994-11-17
AU650800B2 (en) 1994-06-30
JPH05246996A (ja) 1993-09-24
AU2859792A (en) 1993-06-03
HU9203732D0 (en) 1993-03-29
ZA929175B (en) 1993-05-25
DE59200789D1 (de) 1994-12-22
GR3014990T3 (en) 1995-05-31
ATE114115T1 (de) 1994-12-15

Similar Documents

Publication Publication Date Title
HK1003708A1 (en) Peripheral vasodilating agent containing n-acylated 4-amino piperidine derivatives as active ingredients
ES2017838A6 (es) Un procedimiento de preparacion de derivados de 4h-1-benzopiran-4-ona o sus sales.
KR950016732A (ko) 피부 및 질의 위축 억제방법
PH25859A (en) Composition for treatment of ischemic disorder
ES2089665T3 (es) Terazosina polimorfa y composicion farmaceutica.
ES2108129T3 (es) Nuevos derivados de pirazina, su preparacion y empleo.
KR960706472A (ko) 프로스타글란딘 유도체, 그의 염 및 그의 사용
MY106314A (en) New tetrazole derivatives, process for their preparation and their use
KR890014480A (ko) 2-피리딜아세트산 유도체, 이의 제조방법 및 이를 함유하는 약제학적 조성물
MD502G2 (ro) Derivaţi noi ai adenozinei, procedee de preparare a lor, compoziţii farmaceutice ce le conţin
TR200000153T2 (tr) İl-5 inhibite eden 6-azaurasil türevleri.
ES2046641T3 (es) Composicion antitumoral.
TW325469B (en) 5,6-Dihydro-dibenz[b,e]azepine-6,11-dione-11-oximes
DE69128630D1 (de) Benzopyran derivat, seine darstellung und pharmazeutische zusammensetzung, welche dieses enthält
ES475533A1 (es) Un metodo para la preparacion de formas racemicas y optica- mente activas de 2-(4-difenilil)-n-(dimetilamino-alquil)pro-pionamida
IL95762A0 (en) Benzanilides,their preparation and pharmaceutical compositions containing the same
GB1356873A (en) Fungicidal compositions and their use
TW280810B (fr)
DE3563048D1 (en) 2-pyridine-thiol derivatives, processes for their preparation and pharmaceutical compositions containing them
IL103417A (en) Alkyl 5- 2-(2, 5-dialkoxyphenyl) ethyl9-2-hydroxybenzoates their preparation and pharmaceutical compositions containing them
KR940014411A (ko) 신규 세팔로스포린계 항생제(v)
JPS6416712A (en) Hair tonic
SE9803280D0 (sv) Novel compounds
EP0086756A3 (fr) Compositions dermatologiques basées sur des thiolesters mercaptopropionylamidoacétiques
KR900018040A (ko) 생리활성을 갖는 신규의 피라졸 설포네이트 유도체